Novo Nordisk calls extraordinary general meeting to elect new board members

Novo Nordisk A/S (NYSE:NVO) announced Tuesday it will hold an Extraordinary General Meeting on Friday, November 14, 2025, to elect new members to its Board of Directors. The meeting will be conducted fully electronically, allowing shareholders to participate virtually or view a live webcast on the company’s website.

According to the company’s statement, Chair Helge Lund, Vice Chair Henrik Poulsen, and board members Laurence Debroux, Andreas Fibig, Sylvie Grégoire, Christina Law, and Martin Mackay will not stand for election at the upcoming meeting. Kasim Kutay and employee-elected board members Elisabeth Dahl Christensen, Liselotte Hyveled, Mette Bøjer Jensen, and Thomas Rantzau will remain on the board.

The Novo Nordisk Foundation and Novo Holdings A/S have proposed the following candidates for election until the next Annual General Meeting: Lars Rebien Sørensen as Chair, Cees de Jong as Vice Chair, and Britt Meelby Jensen, Mikael Dolsten, and Stephan Engels as board members. If all nominees are elected, the board will consist of six shareholder-elected members and four employee-elected members.

The company stated that the proposed board composition aims to ensure a mix of relevant competencies and experience, including global leadership, healthcare, finance, and direct-to-consumer marketing. With trailing twelve-month revenue of $4.83 million and a healthy current ratio of 3.05, the new board will oversee a financially stable operation. The board also outlined diversity aspirations, targeting a balance of Nordic and non-Nordic nationalities and gender representation by 2026. For deeper insights into Novo Nordisk’s financial metrics and governance analysis, InvestingPro subscribers have access to over 30 additional key indicators and expert recommendations.

Shareholders registered at the close of business on Friday, November 7, 2025, will be eligible to participate and vote. Proxies must be received by Monday, November 10, 2025, and votes by correspondence by Thursday, November 13, 2025.

This information is based on a press release statement and an SEC filing.

In other recent news, REE Automotive Ltd. has announced a special general meeting of shareholders set for November 13, 2025, at its headquarters in Kibbutz Glil-Yam, Israel. The company has provided a proxy statement and a form of proxy card for the meeting, detailing the proposals to be voted on. Meanwhile, Erayak Power Solution Group Inc. has entered into an at-the-market sales agreement with Craft Capital Management LLC, allowing it to offer and sell up to $10 million of its Class A ordinary shares. AstraZeneca PLC has revealed plans to harmonize its share listing across the London Stock Exchange, Nasdaq Stockholm, and the New York Stock Exchange, aiming to replace its current US ADRs with a direct listing of ordinary shares on the NYSE.

Enlivex Therapeutics Ltd. has scheduled its Annual General Meeting of Shareholders for November 10, 2025, at its offices in Nes Ziona, Israel. The company has released a notice and proxy statement but did not disclose the agenda details in the announcement. Additionally, B.O.S. Better Online Solutions Ltd. is preparing for its annual shareholder meeting on October 23, 2025, in Rishon LeZion, Israel, with proxy materials available for shareholders. These recent developments highlight significant activities and strategic moves among various companies, providing investors with essential information for decision-making.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.